Medicare Enrolled
Dr. Rana Mahmood, MD
Optician · Decatur, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahmood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahmood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahmood
Dr. Rana Mahmood is an optician specialist in Decatur, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mahmood performed 1,809 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mahmood received a total of $25,460 from 59 pharmaceutical and/or device companies across 384 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahmood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 34% volume in IL
$25,460 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,809
Medicare services
Top 34% in IL for optician
Not available
Unique patients (not deduplicated)
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
495 | $68 | $138 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $87 | $151 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $57 | $102 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $117 | $235 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
103 | $173 | $414 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
86 | $133 | $484 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
85 | $142 | $454 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
79 | $43 | $437 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
79 | $100 | $199 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
58 | $116 | $337 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
57 | $70 | $300 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
48 | $89 | $195 |
| Injection, methylprednisolone acetate, 40 mg | 45 | $5 | $52 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
26 | $93 | $186 |
| New patient office visit, complex (60-74 min) | 23 | $146 | $293 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
18 | $203 | $375 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
17 | $75 | $143 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $63 | $105 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm or cool water to evaluate inner ear function. |
16 | $15 | $36 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$25,460
Total received (2018-2024)
Avg $3,637/year across 7 years
Top 4% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
384
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,981
2023
$696
2022
$6,608
2021
$9,220
2020
$5,511
2019
$746
2018
$698
Payments by company (2024)
Inspire Medical Systems, Inc.
$512
Alexion Pharmaceuticals, Inc.
$500
ABBVIE INC.
$193
Supernus Pharmaceuticals, Inc.
$107
CSL Behring
$62
UCB, Inc.
$56
MDD US Operations, LLC
$55
JAZZ PHARMACEUTICALS INC.
$53
Avadel CNS Pharmaceuticals, LLC
$51
Eisai Inc.
$46
Lilly USA, LLC
$44
LivaNova USA, Inc.
$39
Neurelis, Inc.
$34
ARGENX US, INC.
$32
Lundbeck LLC
$31
REVANCE THERAPEUTICS, INC.
$28
HARMONY BIOSCIENCES LLC
$23
Genentech USA, Inc.
$19
EMD Serono, Inc.
$17
Novartis Pharmaceuticals Corporation
$17
Biogen, Inc.
$16
ACADIA Pharmaceuticals Inc
$15
Teva Pharmaceuticals USA, Inc.
$15
Celgene Corporation
$14
Top 3 companies account for 60.8% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$7,058
Biohaven Pharmaceutical Holding Company Ltd.
$4,769
Biohaven Pharmaceuticals, Inc.
$4,456
AbbVie Inc.
$1,933
LivaNova USA, Inc.
$1,856
Inspire Medical Systems, Inc.
$673
Alexion Pharmaceuticals, Inc.
$530
Supernus Pharmaceuticals, Inc.
$496
ABBVIE INC.
$357
UCB, Inc.
$268
Novartis Pharmaceuticals Corporation
$247
CSL Behring
$195
ACADIA Pharmaceuticals Inc
$193
Allergan Inc.
$186
GENZYME CORPORATION
$164
Celgene Corporation
$141
EMD Serono, Inc.
$140
Lilly USA, LLC
$136
Jazz Pharmaceuticals Inc.
$129
Amgen Inc.
$128
JAZZ PHARMACEUTICALS INC.
$124
Janssen Pharmaceuticals, Inc
$112
ARGENX US, INC.
$110
MDD US Operations, LLC
$77
Teva Pharmaceuticals USA, Inc.
$59
Biogen, Inc.
$57
Upsher-Smith Laboratories LLC
$56
Avadel CNS Pharmaceuticals, LLC
$51
Neurelis, Inc.
$47
Eisai Inc.
$46
CATALYST PHARMACEUTICALS, INC.
$45
Merz Pharmaceuticals, LLC
$41
Sunovion Pharmaceuticals Inc.
$39
Sumitomo Pharma America, Inc.
$38
UPSHER-SMITH LABORATORIES LLC
$34
Lundbeck LLC
$31
IMPEL PHARMACEUTICALS INC.
$29
REVANCE THERAPEUTICS, INC.
$28
US WorldMeds, LLC
$28
PFIZER INC.
$28
Axsome Therapeutics, Inc.
$28
Kyowa Kirin, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$26
TerSera Therapeutics LLC
$24
HARMONY BIOSCIENCES LLC
$23
Genentech USA, Inc.
$19
Promius Pharma LLC
$17
Adamas Pharmaceuticals, Inc.
$16
Avanir Pharmaceuticals, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Grifols USA, LLC
$15
Merck Sharp & Dohme Corporation
$14
Mallinckrodt Enterprises LLC
$13
OWP Pharmaceuticals, Inc.
$13
SK Life Science, Inc.
$13
Assertio Therapeutics, Inc.
$13
Acorda Therapeutics, Inc
$12
Mallinckrodt LLC
$11
Impax Laboratories, Inc.
$11
Top 3 companies account for 64.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APOKYN · APTIOM · Aimovig · Apokyn · BELSOMRA · BOTOX · Briviact · DAXXIFY · DISEASE STATE · DYSPORT · Dysport · EMGALITY · FIRDAPSE · GOCOVRI · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INSPIRE · KESIMPTA · KYNMOBI · LEMTRADA · LUMRYZ · Lamotrigine Starter Kit · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · PRIALT · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · RYTARY · Rebif · Rystiggo · Soliris · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
9
County median income
$62,449
Nearest hospital to ZIP centroid (approximate)
ST MARYS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahmood is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahmood experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Mahmood performed 495 electromyography of arm or leg muscles services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mahmood receive payments from pharmaceutical companies?
Yes. Dr. Mahmood received a total of $25,460 from 59 companies across 384 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahmood's costs compare to other opticians in Decatur?
Dr. Mahmood's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahmood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Decatur
Browse opticians in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology